Cargando…
Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
Autores principales: | Chevret, Sylvie, Bouadma, Lila, Dupuis, Claire, Burdet, Charles, Timsit, Jean‑Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541350/ https://www.ncbi.nlm.nih.gov/pubmed/37773550 http://dx.doi.org/10.1186/s13613-023-01194-x |
Ejemplares similares
-
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
por: Chevret, Sylvie, et al.
Publicado: (2023) -
Atlas Covidicus
por: Newman, Jamie
Publicado: (2021) -
Natural light exposure and delirium in ICU: does the dark side cloud everything?
por: Sonneville, Romain, et al.
Publicado: (2020) -
Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis
por: Dupuis, Claire, et al.
Publicado: (2017) -
Ultrasound guidance and risk for intravascular catheter-related infections among peripheral arterial catheters: a post-hoc analysis of two large randomized-controlled trials
por: Buetti, Niccolò, et al.
Publicado: (2020)